Balyasny Asset Management LLC Revolution Medicines, Inc. Transaction History
Balyasny Asset Management LLC
- $58 Billion
- Q3 2024
A detailed history of Balyasny Asset Management LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Balyasny Asset Management LLC holds 1,651,805 shares of RVMD stock, worth $69 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
1,651,805
Previous 2,363,584
30.11%
Holding current value
$69 Million
Previous $91.7 Million
18.41%
% of portfolio
0.13%
Previous 0.17%
Shares
8 transactions
Others Institutions Holding RVMD
# of Institutions
268Shares Held
161MCall Options Held
260KPut Options Held
620K-
Vanguard Group Inc Valley Forge, PA14.9MShares$623 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$560 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$476 Million0.09% of portfolio
-
Farallon Capital Management LLC San Francisco, CA11.3MShares$473 Million2.58% of portfolio
-
Baker Bros. Advisors LP New York, NY7.57MShares$316 Million3.67% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.66B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...